Trials / Completed
CompletedNCT01556126
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,191 (actual)
- Sponsor
- CID - Carbostent & Implantable Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate safety and efficacy performances of CRE8 Drug Eluting Stent, in patients comparable to the everyday's clinical practice population, with a specific focus on diabetics, that will be part of a pre-specified study subgroup.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Amphilimus Eluting Stent (CRE8) | Sirolimus formulated coronary eluting stent |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2014-07-01
- Completion
- 2018-12-01
- First posted
- 2012-03-16
- Last updated
- 2021-07-20
Locations
23 sites across 6 countries: Austria, Belgium, Italy, Netherlands, Norway, Poland
Source: ClinicalTrials.gov record NCT01556126. Inclusion in this directory is not an endorsement.